Award - World Trade Center Health Program - Survivor Clinical Center of Excellence

Award Notice Posted

Solicitation number
CDC-75D301-WTCHP-Award
Agency
Awarded
to New York City Health And Hospitals Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
75D30125C20641 Federal contract award
Place of performance
New York, New York 10004, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, awarded Contract No. 75D301-25-C-20641 to the New York City Health and Hospitals Corporation on September 26, 2025, to establish a Survivor Clinical Center of Excellence for the World Trade Center Health Program. The contract provides healthcare services including health monitoring, diagnosis, and treatment to eligible survivors of the September 11, 2001 terrorist attacks residing in the New York Metropolitan Area. The cost-reimbursable contract has a total estimated cost ceiling of $165,914,538 and covers a base performance period from September 29, 2025, to September 28, 2026, with four additional 12-month option periods available. This program is authorized under the James Zadroga 9/11 Health and Compensation Act of 2010 and specifically addresses health conditions linked to exposure to airborne toxins and other hazards from the 9/11 attacks.

Notice text

On September 26, 2025, the Centers for Disease Control and Prevention (CDC), Office of Acquisition Services, awarded Contract No. 75D301-25-C-20641 on behalf of the National Institute for Occupational Safety and Health (NIOSH) / World Trade Center Health Program (WTCHP) to the New York City Health and Hospitals Corporation. The contract establishes a Survivor Clinical Center of Excellence (CCE) to provide healthcare services, including health monitoring, diagnosis, and treatment, to current and future eligible Survivors of the September 11, 2001 (9/11) terrorist attacks residing in the New York Metropolitan Area.

The contract is awarded as cost-reimbursable (no fee or profit) with a total estimated cost ceiling of $165,914,538, covering a base performance period from September 29, 2025, to September 28, 2026, with four additional 12-month option periods.

The WTCHP is authorized by Title I of the James Zadroga 9/11 Health and Compensation Act of 2010 (Zadroga Act) and is a limited health benefit program, meaning that treatment is only available for specific covered health condition(s) for which exposure to airborne toxins, any other hazard, or any other adverse condition resulting from the 9/11, terrorist attacks has been determined to be substantially likely to be a significant factor in aggravating, contributing to, or causing the illness or health condition in an individual member. The Program is administered by the NIOSH, part of the CDC, a component of the Department of Health and Human Services, and provides medical monitoring, screening, and treatment for Program members. Members comprise of Responders to the 9/11 terrorist attacks in New York City (NYC), Responders at the Pentagon and near Shanksville, Pennsylvania, and Survivors in the NYC Disaster Area.

Awarded contract 75D30125C20641 to NEW YORK CITY HEALTH AND HOSPITALS CORPORATION for 165914538.00 on 2025-09-26.

Notice history

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors